This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Novel chemotherapy and biological agents for metastatic colorectal cancer, combined with surgical advances in liver resection, have resulted in a dramatic increase in survival for patients with advanced disease, according to researchers at The University of Texas M. D. Anderson Cancer Center.
We care about your feedback. Let us know how we can improve your CancerCompass experience.